TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01008956

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.
“Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.”

The sponsor’s own words in the registry.

Life of this trial

20092010201120122013201420152016Registered2009-11-05Planned start2010-04 (planned)Withdrawn (as of)2015-03-23

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
GlaxoSmithKline
Sponsor type
Industry
Conditions
Influenza
Interventions
GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.